Sponsored diagnostic testing programs for Duchenne Muscular Dystrophy (DMD)
A severe X-linked neuromuscular disorder caused by pathogenic variants in the DMD gene. DMD leads to progressive muscle weakness beginning in early childhood and may involve cardiomyopathy and respiratory decline. DMD gene variants also cause the broader spectrum of dystrophinopathies, including Becker muscular dystrophy (BMD) and isolated cardiomyopathy.
3 programs found for Duchenne Muscular Dystrophy (DMD)
Decode Duchenne provides sponsored, no-cost diagnostic testing for suspected Duchenne/Becker muscular dystrophy in patients residing in the U.S. or Canada. The program is administered with Parent Project Muscular Dystrophy and performed by Revvity Omics; industry partners (e.g., Sarepta and others) provide support. Order per clinical presentation; genetic counseling resources are available.
The Detect Muscular Dystrophy Program offers sponsored, no-charge genetic testing and post-test counseling for patients with suspected Duchenne muscular dystrophy, limb-girdle muscular dystrophy, or related neuromuscular disorders. The program is designed to improve access to diagnostic testing, reduce delays in identifying disease etiology, and support clinicians with information that can guide treatment planning and patient counseling.
Roadmap2Rare (Canada) provides complimentary genetic and biochemical testing for suspected rare diseases, delivered by Revvity Omics in collaboration with Sanofi Canada. The program is designed to address unmet testing needs and is available to Canadian clinicians. Test selection and treatment decisions remain at the discretion of the healthcare professional.
